Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Eliana Clark | EVP Chief Technical Officer | 2024-03-04 | 605 | $32.99 | $19.96kSell |
James Basta | EVP General Counsel | 2024-03-04 | 2,297 | $32.99 | $75.78kSell |
Laura Sepplorenzino | EVP Chief Scientific Officer | 2024-01-08 | 1,608 | $28.66 | $46.09kSell |
Laura Sepplorenzino | EVP Chief Scientific Officer | 2024-01-08 | 667 | $29.38 | $19.60kSell |
Eliana Clark | EVP Chief Technical Officer | 2024-01-03 | 307 | $30.12 | $9.25kSell |
James Basta | EVP General Counsel | 2024-01-03 | 3,805 | $29.46 | $112.10kSell |
Glenn Goddard | EVP Chief Financial Officer | 2024-01-03 | 5,365 | $29.46 | $158.05kSell |
Derek Hicks | EVP Chief Business Officer | 2024-01-03 | 3,877 | $29.46 | $114.22kSell |
David Lebwohl | EVP Chief Medical Officer | 2024-01-03 | 5,843 | $29.46 | $172.13kSell |
John M. Leonard | President and CEO | 2024-01-03 | 19,223 | $29.46 | $566.31kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Ark Investment Management LLC | 11.87% | 11,412,449 | $308.36M | Institution |
Blackrock Inc | 9.38% | 9,010,695 | $243.47M | Institution |
Vanguard Group Inc | 8.69% | 8,347,449 | $225.55M | Institution |
Caribou Therapeutics Holdco LLC | 5.82% | 5,593,846 | $151.15M | Insider |
Rachel E. Haurwitz | 5.82% | 5,593,846 | $151.15M | Insider |
State Street Corp | 4.93% | 4,735,861 | $127.96M | Institution |
Novartis Institutes For Biomedical Research Inc | 4.53% | 4,352,295 | $117.60M | Insider |
Caribou Biosciences Inc | 4.16% | 3,994,355 | $107.93M | Insider |
Atlas Venture Associates Ix LP | 3.88% | 3,729,788 | $100.78M | Insider |
Atlas Venture Fund Ix LP | 3.72% | 3,579,788 | $96.73M | Insider |